Jeanette Collins

Jeanette Collins serves as a primary procurement lead within the Defense Health Agency, overseeing critical acquisitions that support the operational readiness of military medical services. She manages a diverse portfolio of contracts focused on pharmaceutical manufacturing, diagnostic and surgical equipment maintenance, and specialized technical services essential to the agency’s mission of delivering high-quality, secure healthcare across global DoD installations. Her work directly enables clinical modernization, supply chain resilience, and the upkeep of advanced medical infrastructure, ensuring that service members, retirees, and their families receive timely, technologically advanced care. Collins maintains consistent partnerships with key vendors including Dependable On-Site Scan & Shred, Inc., Hanith Bioscience, LLC, Livion Technology, LLC, I-2-I Solutions, Inc., and Draeger Inc., reflecting a preference for specialized providers with proven expertise in medical logistics, bioscience innovation, and precision equipment support. Her contracting patterns indicate a reliance on established contractors with niche technical capabilities, often engaging firms capable of rapid deployment, regulatory compliance, and mission-critical service delivery under stringent DoD standards. Her procurement approach prioritizes open competition, with 90% of awards issued under no set-aside status, while maintaining a deliberate 10% commitment to 8(a) competed contracts. This balance reflects a strategic emphasis on technical excellence and mission urgency, while still fostering opportunities for small disadvantaged businesses that meet stringent capability thresholds. Collins’ primary NAICS focus areas include pharmaceutical preparation manufacturing, surgical and medical instrument manufacturing, analytical laboratory instrument manufacturing, and electronic equipment repair and maintenance—all aligned with the agency’s need for integrated clinical solutions. Her expertise lies in procuring high-compliance, FDA- and DoD-regulated products and services that support diagnostics, pharmaceutical distribution, and advanced medical device lifecycle management, ensuring the DHA’s technological and clinical infrastructure remains robust and responsive.